| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/02/2023 | REGENXBIO Inc. | RGNX | Grant | Common Stock | 3.5k | $0.00 | $0 | | 06/02/2023 |
| 06/02/2023 | REGENXBIO Inc. | RGNX | Grant | Stock Options (Right to Buy) | 17.9k | $19.72 | $352.8k | | 06/02/2023 |
| 06/24/2022 | Bausch Health Companies Inc. | BHC | Grant | Common Shares, No Par Value | 34.4k | $0.00 | $0 | | 06/24/2022 |
| 06/03/2022 | REGENXBIO Inc. | RGNX | Grant | Stock Option (Right to Buy) | 15.3k | $22.84 | $350k | | 06/03/2022 |
| 06/03/2022 | REGENXBIO Inc. | RGNX | Grant | Common Stock | 3k | $0.00 | $0 | | 06/03/2022 |
| 06/04/2021 | REGENXBIO Inc. | RGNX | Grant | Stock Option (Right to Buy) | 10k | $35.52 | $355.2k | | 06/04/2021 |
| 05/29/2020 | REGENXBIO Inc. | RGNX | Grant | Stock Option (Right to Buy) | 10k | $37.66 | $376.6k | | 05/29/2020 |
| 05/01/2020 | Bausch Health Companies Inc. | BHC | Grant | Common Shares, No Par Value | 11k | $0.00 | $0 | | 05/01/2020 |
| 05/31/2019 | REGENXBIO Inc. | RGNX | Grant | Stock Option (Right to Buy) | 10k | $43.02 | $430.2k | | 05/31/2019 |
| 05/03/2019 | Bausch Health Companies Inc. | BHC | Grant | Common Stock, No Par Value | 10.6k | $23.51 | $250k | | 05/03/2019 |
| 05/25/2018 | REGENXBIO Inc. | RGNX | Grant | Stock Option (Right to Buy) | 12.5k | $49.45 | $618.1k | | 05/25/2018 |
| 05/03/2018 | Bausch Health Companies Inc. | BHC | Grant | Common Stock, No Par Value | 14.3k | $0.00 | $0 | | 05/03/2018 |
| 05/03/2018 | Bausch Health Companies Inc. | BHC | Grant | Common Stock, No Par Value | 13.9k | $0.00 | $0 | | 05/03/2018 |
| 05/24/2017 | REGENXBIO Inc. | RGNX | Grant | Stock Option (Right to Buy) | 12.5k | $18.85 | $235.6k | | 05/24/2017 |
| 05/05/2017 | Bausch Health Companies Inc. | BHC | Grant | Common Stock, no par value | 25.4k | $0.00 | $0 | | 05/05/2017 |
| 06/01/2016 | REGENXBIO Inc. | RGNX | Grant | Stock Option (Right to Buy) | 12.5k | $12.74 | $159.2k | | 06/01/2016 |
| 09/16/2015 | REGENXBIO Inc. | RGNX | Grant | Stock Option (Right to Buy) | 5.2k | $22.00 | $114.6k | | 09/16/2015 |
| 09/16/2015 | REGENXBIO Inc. | RGNX | Grant | Stock Option (Right to Buy) | 9.4k | $22.00 | $206.2k | | 09/16/2015 |
| 06/24/2015 | ROCKET PHARMACEUTICALS, INC. | RCKT | Grant | Stock Options (Right to Buy) | 12k | $5.03 | $60.4k | | 06/24/2015 |
| 02/23/2015 | ROCKET PHARMACEUTICALS, INC. | RCKT | Conversion | Series AA Convertible Preferred Stock | 4.5M | $0.00 | $0 | See Footnotes | 02/23/2015 |
| 02/23/2015 | ROCKET PHARMACEUTICALS, INC. | RCKT | Conversion | Convertible Promissory Notes | 0 | $0.00 | $0 | See Footnotes | 02/23/2015 |
| 02/23/2015 | ROCKET PHARMACEUTICALS, INC. | RCKT | Purchase | Common Stock | 603.8k | $6.00 | $3.6M | See Footnotes | 02/23/2015 |
| 02/23/2015 | ROCKET PHARMACEUTICALS, INC. | RCKT | Conversion | Common Stock | 1.4M | $0.00 | $0 | See Footnotes | 02/23/2015 |
| 02/23/2015 | ROCKET PHARMACEUTICALS, INC. | RCKT | Conversion | Common Stock | 63.6k | $0.00 | $0 | See Footnotes | 02/23/2015 |
| 04/10/2012 | HUMAN GENOME SCIENCES INC | HGSI | Grant | | 1.1k | $7.53 | $8.4k | | 04/10/2012 |